Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Category: Uncategorized

ENHERTU WINS ON DISEASE CONTROL, BUT SURVIVAL SIGNAL PUTS ITS FIRST-LINE AMBITION UNDER PRESSURE

14/09/2026 Published by HealthBiz

Key Development AstraZeneca and Daiichi Sankyo are facing an increasingly complex risk-benefit equation for Enhertu (trastuzumab deruxtecan) in HER2-mutant non-small... Read more

Tags: #Global Trends

GSK’S DRESDEN EXIT SIGNALS A SHIFT FROM LEGACY VACCINE CAPACITY TO NEXT-GENERATION PLATFORMS

14/09/2026 Published by HealthBiz

Key Development GSK plans to close its vaccine manufacturing facility in Dresden, Germany, in the summer of 2027, putting 641... Read more

Category: Uncategorized

Tags: #Global Trends

VIETNAM–U.S. HEALTH COOPERATION TO 2030: FROM TECHNICAL ASSISTANCE TO CO-INVESTMENT AND SYSTEM OWNERSHIP

14/09/2026 Published by HealthBiz

Key Development On September 11, 2026, Vietnam’s Ministry of Health and the U.S. Department of State signed a health cooperation... Read more

Category: Uncategorized

Tags: #Vietnam

FROM IMPORT DEPENDENCE TO TECHNOLOGY OWNERSHIP: VIETNAM BETS ON THREE NEXT-GENERATION VACCINES

14/09/2026 Published by HealthBiz

Key Development Vietnam is moving closer to a significant shift in its vaccine industry: from primarily accessing international products to... Read more

Category: Uncategorized

Tags: #Vietnam

MIFEPRISTONE AT THE INTERSECTION OF FDA AUTHORITY, TELEHEALTH AND STATE ABORTION BANS

11/09/2026 Published by HealthBiz

Key Development A legal battle over mifepristone is evolving into a much broader test of how pharmaceutical regulation, telehealth and... Read more

Category: Uncategorized

Tags: #Global Trends

ABBVIE’S LUNA WIN COULD OPEN A NEW CGRP FRONT IN MENSTRUAL MIGRAINE PREVENTION

11/09/2026 Published by HealthBiz

Key Development AbbVie has reported positive topline results from the Phase 3 LUNA study evaluating atogepant, marketed as Qulipta in... Read more

Category: Uncategorized

Tags: #Global Trends

ROIVANT’S MOSLICIGUAT PHASE 2 WIN COULD RESHAPE THE PH-ILD TREATMENT LANDSCAPE — AND VALIDATE A HIGH-VALUE BIOTECH ASSET STRATEGY

10/09/2026 Published by HealthBiz

Key Development Roivant Sciences has delivered a significant clinical catalyst for its respiratory pipeline after mosliciguat met both primary and... Read more

Category: Uncategorized

Tags: #Global Trends

Who Actually Needs to Change Their Lifestyle?

09/09/2026 Published by Pharma Biz

Lifestyle change is often called the "golden key" to preventing and managing chronic disease — and that's not just a... Read more

Category: Uncategorized

Tags: #Personal Health

Every Employee Can Become a “First Responder”

09/09/2026 Published by Pharma Biz

When people hear "first responder," they typically picture firefighters, paramedics, or police officers — professionals trained to handle emergencies. In... Read more

Category: Uncategorized

Tags: #Corporate Wellness

Posts pagination

Previous page Page 1 … Page 20 Page 21 Page 22 … Page 224 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members